Buffalo, NEW%20YORK8 Active Studies

Rheumatoid Arthritis Clinical Trials in Buffalo, NEW%20YORK

Find 8 actively recruiting rheumatoid arthritis clinical trials in Buffalo, NEW%20YORK. Connect with local research sites and explore new treatment options.

8
Active Trials
8
Sponsors
1,290
Enrolling

Recruiting Rheumatoid Arthritis Studies in Buffalo

RecruitingBuffalo, NEW%20YORKNCT04787042

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab \[Gazyva®\] pre-treatme...

316 participants
Simcha IL-18, Inc.
View Study Details
RecruitingBuffalo, NEW%20YORKNCT06406790

CraniSeal Post Approval Study

To collect post-approval data comparing the safety and effectiveness of CraniSeal Dural Sealant to DuraSeal Dural Sealant. The study has been powered specifically to determine whether the CraniSeal de...

224 participants
Pramand LLC
View Study Details
RecruitingBuffalo, NEW%20YORKNCT05960929

InfasurfAeroâ„¢ Versus Sham Treatment in Preterm Newborns With RDS

The purpose of this clinical study is to determine the effectiveness and safety of Infasurf® administered through the InfasurfAero™, a novel oral airway delivery device specifically designed to give I...

220 participants
ONY
View Study Details
RecruitingBuffalo, NEW%20YORKNCT06450925

Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

The investigators hypothesize that single oral high dose supplementation with vitamin A will reduce the incidence of moderate-severe chronic graft-versus-host disease (GVHD) compared with placebo....

190 participants
Children's Hospital Medical Center, Cincinnati
View Study Details
RecruitingBuffalo, NEW%20YORKNCT06744920

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

A study to evaluate the efficacy, safety and tolerability of Remibrutinib versus placebo in adult patients with Generalized Myasthenia Gravis who are on stable, standard-of-care (SOC) treatment....

180 participants
Novartis Pharmaceuticals
View Study Details
RecruitingBuffalo, NEW%20YORKNCT04683003

A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura (or TTP for short) is a condition where blood clots form in small blood vessels throughout the body. The clots can limit or block the flow of oxygen-rich blood to t...

77 participants
Takeda
View Study Details
RecruitingBuffalo, NEW%20YORKNCT05191706

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCUfor the Treatment of Inflammation Following Ocular Surgery for Chi...

60 participants
EyePoint Pharmaceuticals, Inc.
View Study Details
RecruitingBuffalo, NEW%20YORKNCT04348747

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

This phase IIa trial studies how well dendritic cell vaccines against Her2/Her3 and pembrolizumab work for the treatment of triple negative breast cancer or HER2+ breast cancer or HER+ Breast cancer t...

23 participants
Roswell Park Cancer Institute
View Study Details

About Rheumatoid Arthritis Clinical Trials in Buffalo

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.

There are currently 8 rheumatoid arthritis clinical trials recruiting participants in Buffalo, NEW%20YORK. These studies are seeking a combined 1,290 participants. Research is being sponsored by Simcha IL-18, Inc., Pramand LLC, ONY and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Rheumatoid Arthritis Clinical Trials in Buffalo — FAQ

Are there rheumatoid arthritis clinical trials in Buffalo?

Yes, there are 8 rheumatoid arthritis clinical trials currently recruiting in Buffalo, NEW%20YORK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Buffalo?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Buffalo research site will contact you about next steps.

Are clinical trials in Buffalo free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Buffalo studies also compensate for your time and travel.

What rheumatoid arthritis treatments are being tested?

The 8 active trials in Buffalo are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.

Data updated March 2, 2026 from ClinicalTrials.gov